U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06922669) titled 'Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia' on April 03.
Brief Summary: Drug-induced liver injury (DILI) can lead to potentially fatal complications, such as acute liver failure and even death. In clinical practice, glucocorticoids have been considered in some cases of DILI, especially patients with hyperbilirubinemia. However, the available evidence remains controversial and its quality is also very limited. Herein, a multicenter randomized controlled trial (RCT) has been designed to explore the efficacy and safety of glucocorticoids in patients with acute DILI and hyperbilirubinemia.
Study Start ...